Read + Share
Amedeo Smart
Independent Medical Education
Oliveira LJC, Mano MS, Barrios C, Dienstmann R, et al. The promise of ctDNA-based, molecularly-driven early switch therapy from PADA-1 to SERENA-6. Breast Cancer Res Treat 2025;215:5.PMID: 41269338
Email
LinkedIn
Privacy Policy